Thought leadership

Monthly Dealtracker – May 2024

insight featured image

The May edition of the Dealtracker reports subdued monthly deal activity because of the election. The pharma, retail, banking, and real estate sectors attracted notable investments, with healthcare leading in terms of value due to a high-value medical device deal. The election results and the new government's policies are expected to influence future deal activity and private equity (PE) deals.

Key insights

  • Decline in deal volumes: India Inc witnessed 137 deals worth USD 5 billion in May 2024, indicating a 22% decline in volumes and a marginal 3% decrease in values compared to April 2024. PE deal values increased significantly by 49% to USD 4 billion across 99 deals. Despite marking the lowest monthly volume in 2024, the month registered second-highest monthly deal value after January, driven by nine high value deals (~> USD100 million).
  • Important PE transactions: May 2024 reported a total of USD 3,973 million by PE funds, as compared to USD 2,915 million in May 2023. The trend witnessed in April 2024 seemed to continue this month with large deals in FS, healthcare and real estate standing out. Warburg Pincus (Sriram Housing), KKR (Healthium) and Brookefield (commercial portfolio of Bharti Group) are the key deals in the month.